Galapagos NV
GLPG
#4563
Rank
S$2.73 B
Marketcap
S$40.94
Share price
-0.57%
Change (1 day)
13.09%
Change (1 year)

Galapagos NV (GLPG) - Cash on Hand

Cash on Hand as of September 2025 : S$4.63 Billion

According to Galapagos NV's latest financial reports the company has S$4.63 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Galapagos NV - Cash on Hand chart (from 2008 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31S$4.40 B-18.02%
2023-12-31S$5.37 B-8.63%
2022-12-31S$5.88 B-18.24%
2021-12-31S$7.20 B-14.26%
2020-12-31S$8.39 B-3.8%
2019-12-31S$8.73 B332.78%
2018-12-31S$2.01 B9.2%
2017-12-31S$1.84 B24.69%
2016-12-31S$1.48 B181.49%
2015-12-31S$0.52 B74.48%
2014-12-31S$0.30 B24.77%
2013-12-31S$0.24 B57.91%
2012-12-31S$0.15 B179.63%
2011-12-31S$54.75 M-20.9%
2010-12-31S$69.21 M-27.39%
2009-12-31S$95.32 M74.54%
2008-12-31S$54.61 M-47.27%
2007-12-31S$0.10 B-0.64%
2006-12-31S$0.10 B123.78%
2005-12-31S$46.58 M104.88%
2004-12-31S$22.73 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
AstraZeneca
AZN
S$10.60 B 128.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
S$24.05 B 418.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$13.54 B 191.99%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
S$7.34 B 58.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
S$96.39 M-97.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$10.02 B 116.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$2.85 B-38.46%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
S$5.75 B 24.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
S$23.60 B 408.83%๐Ÿ‡บ๐Ÿ‡ธ USA